Arcus Biosciences, Inc.
RCUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$283 | -$307 | -$267 | $53 |
| Dep. & Amort. | $10 | $8 | $14 | $4 |
| Deferred Tax | $0 | $0 | $0 | $5 |
| Stock-Based Comp. | $76 | $73 | $0 | $55 |
| Change in WC | $22 | -$71 | $623 | -$376 |
| Other Non-Cash | $5 | -$9 | $68 | $3 |
| Operating Cash Flow | -$170 | -$306 | $438 | -$256 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$24 | -$6 | -$26 |
| Net Acquisitions | $0 | $0 | $0 | -$22 |
| Inv. Purchases | -$1,043 | -$788 | -$1,241 | -$719 |
| Inv. Sales/Matur. | $965 | $1,006 | $837 | $741 |
| Other Inv. Act. | $0 | $0 | -$3 | $22 |
| Investing Cash Flow | -$84 | $194 | -$413 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $47 | $0 | $10 | $5 |
| Stock Issued | $228 | $25 | $23 | $220 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $8 | $0 | $12 |
| Financing Cash Flow | $277 | $33 | $33 | $237 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $23 | -$79 | $58 | -$23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $130 | $209 | $148 | $174 |
| End Cash | $153 | $130 | $206 | $151 |
| Free Cash Flow | -$176 | -$330 | $432 | -$282 |